e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.80p
   
  • Change Today:
      0.20p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 2,327,452
  • Market Cap: £57.26m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
17-Aug-15 N 1 Singer Corporate 39.00p - - Reiteration
16-Sep-14 Panmure Gordon Buy - - 70.00p Reiteration
08-May-14 Panmure Gordon Buy - 70.00p 70.00p Reiteration
26-Mar-14 Panmure Gordon Buy - 70.00p 70.00p Reiteration
07-Jan-14 Panmure Gordon Buy - 70.00p 70.00p Reiteration
21-Oct-13 Panmure Gordon Buy - 70.00p 70.00p Reiteration
11-Oct-13 Panmure Gordon Buy - 70.00p 70.00p Reiteration
10-May-13 Panmure Gordon Buy - 72.00p 67.00p Reiteration
18-Dec-12 Panmure Gordon Buy - 73.00p 73.00p Reiteration
22-Oct-12 Panmure Gordon Buy - 76.00p 73.00p Reiteration
19-Jun-12 Panmure Gordon Buy - 76.00p - Reiteration
21-May-12 Panmure Gordon Buy - 76.00p - Reiteration
18-Oct-11 Panmure Gordon Buy - 76.00p - Reiteration
22-Jul-11 Panmure Gordon Buy - 80.00p - Reiteration
15-Feb-11 Panmure Gordon Buy - 80.00p - Reiteration
30-Sep-10 Panmure Gordon Buy - - 80.00p New Coverage

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.80p
Change Today 0.20p
% Change 2.08 %
52 Week High 23.10
52 Week Low 8.13
Volume 2,327,452
Shares Issued 584.34m
Market Cap £57.26m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.8% below the market average23.8% below the market average23.8% below the market average23.8% below the market average23.8% below the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Price Trend
62.48% below the market average62.48% below the market average62.48% below the market average62.48% below the market average62.48% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Income Not Available
Growth
14.95% below the market average14.95% below the market average14.95% below the market average14.95% below the market average14.95% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 162,886 @ 9.80p
16:35 93,587 @ 9.80p
16:35 28,578 @ 9.80p
16:35 40,721 @ 9.80p
16:29 10,461 @ 9.80p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page